HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stavroula Masouridi-Levrat Selected Research

Chimeric Antigen Receptors

1/2019[Management of cytokine release syndrome in adult and pediatric patients undergoing CAR-T cell therapy for hematological malignancies: Recommendation of the French Society of Bone Marrow and cellular Therapy (SFGM-TC)].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Stavroula Masouridi-Levrat Research Topics

Disease

17Infections
11/2023 - 11/2015
4Neoplasms (Cancer)
01/2024 - 11/2015
4Hematologic Neoplasms (Hematological Malignancy)
09/2023 - 09/2014
3Graft vs Host Disease (Graft-Versus-Host Disease)
11/2022 - 01/2016
2Hodgkin Disease (Hodgkin's Disease)
01/2024 - 02/2023
2Pathologic Complete Response
02/2023 - 01/2023
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2021 - 01/2021
2Cytokine Release Syndrome
01/2020 - 01/2019
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2018 - 05/2015
1Blast Crisis (Blast Phase)
05/2024
1Fever (Fevers)
12/2023
1Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2023
1Hematologic Diseases (Blood Diseases)
11/2022
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
11/2022
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
08/2022
1COVID-19
08/2022
1Human Influenza (Influenza)
01/2022
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2022
1Renal Insufficiency (Renal Failure)
12/2021
1Cytomegalovirus Infections (Inclusion Disease)
01/2021
1Breakthrough Infections
01/2021
1Viremia
11/2020
1Pseudomonas Infections
07/2020
1Brain Diseases (Brain Disorder)
01/2020
1Encephalitis (Encephalitis, Rasmussen)
01/2019
1Disease Progression
01/2017
1Cytopenia
11/2016
1Inflammation (Inflammations)
01/2016
1Bone Marrow Failure Disorders
01/2016

Drug/Important Bio-Agent (IBA)

4letermovirIBA
04/2023 - 01/2021
2Tyrosine Kinase InhibitorsIBA
05/2024 - 01/2022
2Anti-Bacterial Agents (Antibiotics)IBA
12/2023 - 07/2020
1Brentuximab VedotinIBA
01/2024
1pembrolizumabIBA
01/2024
1Immunoglobulin G (IgG)IBA
09/2023
1Sorafenib (BAY 43-9006)FDA Link
01/2023
1pritelivirIBA
01/2023
1Acyclovir (Aciclovir)FDA LinkGeneric
01/2023
1defibrotideIBA
11/2022
1VaccinesIBA
08/2022
1Inosine Triphosphate (ITP)IBA
08/2022
1mRNA VaccinesIBA
08/2022
1isavuconazoleIBA
12/2021
1ValganciclovirFDA Link
04/2021
1DNA (Deoxyribonucleic Acid)IBA
11/2020
1Interleukin-6 (Interleukin 6)IBA
01/2020
1Antiviral Agents (Antivirals)IBA
01/2019
1Chimeric Antigen ReceptorsIBA
01/2019
1ponatinibIBA
01/2017
1Fas Ligand Protein (Fas Ligand)IBA
01/2016
1InterferonsIBA
01/2016
1Prostaglandins FIBA
01/2016
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016

Therapy/Procedure

11Hematopoietic Stem Cell Transplantation
01/2024 - 05/2015
6Cell Transplantation
11/2023 - 01/2018
6Transplantation
02/2023 - 09/2014
5Therapeutics
02/2023 - 01/2017
2Duration of Therapy
02/2022 - 07/2020
1Splenectomy
08/2022
1Stem Cell Transplantation
01/2021
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2020
1Homologous Transplantation
11/2016